SCYNEXIS, Inc. (SCYX) Announces First Participants Dosed in Phase 1 Trial of SCY-247 Antifungal Therapy
On February 26, 2026, SCYNEXIS, Inc.
Scynexis Inc (SCYX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Propel Bio Management Leen Kawas And Richard Kayne | 543,478 | $2,211,955 | 1.16% | |
| 2. | Nierenberg Investment Management David Nierenberg | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 108,695 | $0.00 | 1,357,126 | 2026-04-01 | Filing | |
| $1.37 | 20,000 | $27,400.00 | 507,871 | 2024-09-12 | Filing | |
| $3.00 | 75,000 | $225,000.00 | 272,068 | 2022-04-26 | Filing | |
| $3.00 | 3,500 | $10,500.00 | 53,499 | 2022-04-26 | Filing | |
| $6.25 | 8,000 | $50,000.00 | 8,000 | 2020-12-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.95 | 33,849 | $302,948.55 | 1,800,000 | 2021-01-22 | Filing | |
| $8.16 | 285,151 | $2,326,832.16 | 1,833,849 | 2021-01-22 | Filing | |
| $7.38 | 95,000 | $701,100.00 | 2,120,000 | 2021-01-21 | Filing | |
| $7.43 | 185,000 | $1,374,550.00 | 2,215,000 | 2021-01-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 126,451 | $514,656 | 0.6% | |
| 2. | 82,093 | $334,169 | 0% | |
| 3. | 41,522 | $168,995 | 0% | |
| 4. | 13,874 | $56,467 | 0.02% | |
| 5. | 11,223 | $45,678 | 0% |
News See All
11 Fastest Growing Penny Stocks to Buy Right Now
Interest in smaller companies has been quietly building on Wall Street.
SCYNEXIS Reports Positive Phase 1 Results for Second-Generation Antifungal SCY-247
SCYNEXIS Inc. (NASDAQ:SCYX) is one of the best long term penny stocks with huge upside potential.
10 Best Long Term Penny Stocks with Huge Upside Potential
On October 2, Dan Veru, Palisade Capital Management senior partner and CIO, joined 'Power Lunch' on CNBC to discuss the opportunities available in small-cap stocks and talk about the start of the first...
SCYNEXIS, Inc. (SCYX) Resumes Phase III Dosing for Brexafemme After 19-Month FDA Hold
SCYNEXIS, Inc. (NASDAQ:SCYX) has officially restarted patient dosing in its Phase III MARIO trial for Brexafemme (ibrexafungerp) after the FDA lifted a nearly two-year clinical hold.
14 Cheap Penny Stocks to Buy According to Analysts
In this article, we will take a detailed look at the 14 Cheap Penny Stocks to Buy According to Analysts. For a quick overview of such stocks, read our article 5 Cheap Penny Stocks to Buy According...
11 Cheapest Stocks With Biggest Upside
In this piece, we will take a look at the 11 cheapest stocks with the biggest upside.
10 Best Fast Growing Penny Stocks to Buy Now
The second half of 2023 started with a strong optimism on the back of hopes that the long-anticipated recession which everyone was talking about might never realize, thanks to cooling inflation, strong...
Michael Burry Is Selling These 3 Stocks
Lockheed Martin Corporation (NYSE:LMT) is an aerospace and defense firm.
Top 3 Stock Picks of Michael Burry
CoreCivic, Inc. (NYSE:CXW) owns and runs correctional and detention facilities. The company has a market cap of $1.1 billion and posted more than $1.9 billion in revenue last year.
Hedge Fund Resource Center